• Citer

Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors.

par McBride, David J;Orpana, Arto K;Sotiriou, Christos ;Joensuu, Heikki;Stephens, Philip J;Mudie, Laura J;Hämäläinen, Eija;Stebbings, Lucy A;Andersson, Leif C;Flanagan, Adrienne M;Durbecq, Virginie ;Ignatiadis, Michail ;Kallioniemi, Olli;Heckman, Caroline A;Alitalo, Kari;Edgren, Henrik;Futreal, P Andrew;Stratton, Michael R;Campbell, Peter J
Référence Genes chromosomes & cancer, 49, 11, page (1062-1069)
Publication Publié, 2010-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors.
Auteur:	McBride, David J; Orpana, Arto K; Sotiriou, Christos; Joensuu, Heikki; Stephens, Philip J; Mudie, Laura J; Hämäläinen, Eija; Stebbings, Lucy A; Andersson, Leif C; Flanagan, Adrienne M; Durbecq, Virginie; Ignatiadis, Michail; Kallioniemi, Olli; Heckman, Caroline A; Alitalo, Kari; Edgren, Henrik; Futreal, P Andrew; Stratton, Michael R; Campbell, Peter J
Informations sur la publication:	Genes chromosomes & cancer, 49, 11, page (1062-1069)
Statut de publication:	Publié, 2010-11
Sujet CREF:	Cancérologie
MeSH keywords:	Adult
	Breast Neoplasms -- drug therapy -- genetics -- pathology
	Female
	Gene Rearrangement
	Humans
	Middle Aged
	Osteosarcoma -- drug therapy -- genetics -- pathology
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	FLWIN
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1045-2257
	info:doi/10.1002/gcc.20815
	info:scp/77957911880
	info:pmid/20725990
	PMC3145117